
Five Interventions for Treating Multidrug-Resistant TB
The FDA has approved a drug combination that could be a game changer. We should make sure its use is equitable and sustainable
Ifeanyi Nsofor is a medical doctor, CEO of EpiAFRIC and director of policy and advocacy at Nigeria Health Watch. He is a 2019 Atlantic Fellow for Health Equity at George Washington University and a Senior New Voices Fellow at the Aspen Institute. He has written opinion pieces for Inter Press Service, Project Syndicate, the Hill, Devex, African Arguments, AllAfrica and Vanguard. EpiAFRIC
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account